Xtant Medical Announces FDA Clearance of the Xspan™

Xtant Medical Holdings, Inc. XTNT today announced that its wholly owned subsidiary, X-spine Systems, received FDA clearance of the Xspan™ Laminoplasty Fixation System. The Xspan™ System represents the latest generation of laminoplasty fixation. Spinal laminoplasty is a surgical procedure performed to remove pressure from the spinal cord. Xtant Medical estimates the worldwide market for laminoplasty at $110M and growing. Xspan will be available to a limited number of key surgeons in the second fiscal quarter of 2016, with a larger general release to follow later in 2016. Dr. David Kirschman, CSO, EVP, and Director of Xtant Medical said "This system will allow Xtant Medical to further differentiate itself from the competition and will better serve the growing needs of our surgeon partners." Shares of Xtant Medical are up 14.29 percent Wednesday.